Clinicopathologic Characteristics of 42 Cases of Krukenberg Tumor of the Ovary.
- Author:
Yong Jung SONG
1
;
Byoung Sun YOON
;
Hyun Hee KIM
;
Joon Tae AHN
;
Suck Chul CHOI
;
Sang Young RYU
;
Jong Hoon KIM
;
Byoung Gie KIM
;
Sang Yoon PARK
;
Kyung Hee LEE
Author Information
1. Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Krukenberg tumor;
5-year survival;
prognostic factor
- MeSH:
Ascites;
Chemotherapy, Adjuvant;
Colon;
Diagnosis;
Drug Therapy;
Female;
Gallbladder;
Humans;
Krukenberg Tumor*;
Ovary*;
Prognosis;
Retrospective Studies;
Stomach;
Survival Rate
- From:Korean Journal of Obstetrics and Gynecology
2001;44(12):2243-2249
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: This study is to investigate clinicopathologic characteristics, survival and prognostic factors in patients with Krukenberg tumor of the ovary. MATERIAL & METHODS: From Jan. 1991 to Dec. 2000, 42 patients with Krukenberg tumor of the ovary were investigated with clinical profiles, such as age, stage, primary sites, clinical symptoms, and survival, retrospectively. RESULTS: A mean age of 42 patients was 44.8 years (range 27-77). Stomach was the most frequent primary site (30/42, 71.4%), followed by colon (7/42, 16.7%) and gallbladder (1/42, 2.4%). In 38 patients, primary sites diagnosed before or after 1 month of diagnosis of Krukenberg tumor of ovary (36/38 cases, 94.7%). The most common feature of patients with Krukenberg tumor of ovary was bilateral abdominal mass. 5-year survival rate of patients with Krukenberg tumor of ovary was 8.94% (95% CI=3.33-14.55) and median survival time was 11 months. Age, bilaterality of tumor, time of diagnosis, presence of ascites and the primary site did not affect the survival. The patients who received post-operative adjuvant chemotherapy had better 3-year survival than those who did not (17.28% vs 10% p=0.03). CONCLUSION: Krukenberg tumor of the ovary is an aggressive tumor with poor prognosis. Post-operative adjuvant chemotherapy may increase the survival of patients with Krukenberg tumor of the ovary. Further prospective studies for the role of surgery and chemotherapy are needed.
